Publications

Search
Found 6 results
Filters: Author is Zhang, F.  [Clear All Filters]
Journal Article
Lu CY, Law M., Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of Prior Authorization on the Use and Costs of Lipid-Lowering Medications Among Michigan and Indiana Dual Enrollees in Medicaid and Medicare: Results of a Longitudinal, Population-Based Study. Clinical Therapeutics. 2011;33(1):135-144.
Lu CY, Law M., Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clinical Therapeutics. 2011;33(1):135-144.
Law M., Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: Results of a longitudinal, population-based study. Clinical therapeutics. 2010;32(4):729-741.
Law M., Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, et al. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clinical therapeuticsClin.Ther.. 2010;32(4):729-41; discussion 716.
Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law M., et al. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Affairs. 2008;27(3):w185-w195.
Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law M., et al. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health affairs (Project Hope)Health.Aff.(Millwood). 2008;27(3):w185-95.